Polysaccharides-based nanocarriers enhance the anti-inflammatory effect of curcumin

Carbohydr Polym. 2023 Jul 1:311:120718. doi: 10.1016/j.carbpol.2023.120718. Epub 2023 Feb 25.

Abstract

Curcumin (CUR) has been discovered to have many biological activities, including anti-inflammatory, anti-cancer, anti-oxygenation, anti-human immunodeficiency virus, anti-microbial and exhibits a good effect on the prevention and treatment of many diseases. However, the limited properties of CUR, including the poor solubility, bioavailability and instability caused by enzymes, light, metal irons, and oxygen, have compelled researchers to turn their attention to drug carrier application to overcome these drawbacks. Encapsulation may provide potential protective effects to the embedding materials and/or have a synergistic effect with them. Therefore, nanocarriers, especially polysaccharides-based nanocarriers, have been developed in many studies to enhance the anti-inflammatory capacity of CUR. Consequently, it's critical to review current advancements in the encapsulation of CUR using polysaccharides-based nanocarriers, as well as further study the potential mechanisms of action where polysaccharides-based CUR nanoparticles (the complex nanoparticles/Nano CUR-delivery systems) exhibit their anti-inflammatory effects. This work suggests that polysaccharides-based nanocarriers will be a thriving field in the treatment of inflammation and inflammation-related diseases.

Keywords: Anti-inflammation; Curcumin; Inflammation-related diseases; Polysaccharides-based nanocarrier.

Publication types

  • Review

MeSH terms

  • Curcumin* / pharmacology
  • Drug Carriers
  • Humans
  • Inflammation / drug therapy
  • Nanoparticles*
  • Polysaccharides / pharmacology

Substances

  • Curcumin
  • Drug Carriers
  • Polysaccharides